Orthofix SPAC Presentation Deck
Meaningful Revenue & Cost
Synergy Opportunities.
Revenue
Addresses key product gaps for both
companies (Orthofix: surgical navigation
platform; SeaSpine: motion preservation)
International cross-selling: Orthofix
Spine & Orthopedic established
commercial channels + Sea Spine
biologics & 7D Flash Navigation
Expanded breadth of products in the
sales bag to support large distributor
conversions
Increased product offerings per
procedure
ORTHOFIX®
SeaSpine.
Expected Cost Synergies: $40M*
Reduction of redundant overhead,
and public company costs
Supply chain efficiencies
Working Capital and CapEx
Efficiencies through economies of
scale in spinal implant set and
inventory asset utilization
*Cost synergies of $40M expected by Year 3 with incremental opportunity to reduce
stock-based compensation
8
16
16View entire presentation